This article was originally published in The Gray Sheet
Executive SummaryLee Hulsebus is named president and CEO of the San Diego-based firm. Hulsebus has held positions at firms including Bard and Becton-Dickinson and most recently ran his own health care consulting business. He replaces John Zabsky, who moves to the post of VP of operations for CytoProbe
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.